SCHEDULE 13D/A 1376474-24-000516 0002020621 XXXXXXXX LIVE 10 Common Stock, par value $0.00001 per share 01/07/2026 true 0001808377 45791D109 Innovative Eyewear Inc

11900 BISCAYNE BLVD STE 630 MIAMI FL 33181

Vladimir Galkin (310) 880-6330 10900 NW 97th Street, #102 Miami FL 33178 0002020621 Galkin Vladimir b PF X1 0 0 0 0 0 0 IN Based on 5,350,183 shares of the Issuer's common stock issued and outstanding as of November 6, 2025, based on information reported by the Issuer in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, and filed with the Securities and Exchange Commission (the SEC) on November 13, 2025. 0002038764 Galkin Angelica b PF X1 0 0 0 0 0 0 IN Based on 5,350,183 shares of the Issuer's common stock issued and outstanding as of November 6, 2025, based on information reported by the Issuer in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, and filed with the Securities and Exchange Commission (the SEC) on November 13, 2025. Common Stock, par value $0.00001 per share Innovative Eyewear Inc 11900 BISCAYNE BLVD STE 630 MIAMI FL 33181 This Amendment No. 10 amends the Schedule 13D filed on September 23, 2024 (the "Original Schedule 13D" and, as amended by Amendment No. 1 to Schedule 13D filed on September 23, 2024, and as amended by Amendment No.2 to Schedule 13D filed on September 23, 2024 , and as amended by Amendment No. 3 filed on September 23, 2024, and as amended by Amendment No. 4 filed on September 24, 2024, and as amended by Amendment No. 5 filed on September 25, 2024, and as amended by Amendment No. 6 filed on October 4, 2024, and as amended by Amendment No. 7 filed on December 12, 2025, and as amended by Amendment No. 8 filed on December 29, 2025, and as amended by Amendment No. 9 filed on January 2, 2026, as amended the "Schedule 13D"). This statement of beneficial ownership on Schedule 13D is jointly filed by each of Vladimir Galkin and Angelica Galkin, husband and wife (collectively, the "Reporting Persons" and individually, a "Reporting Person"), with respect to the shares of the common stock, par value $0.00001 per share (the " Common Stock"), of Innovative Eyewear, Inc., a Florida corporation (the " Issuer"). According to the Issuer, the address of its principal executive office is 1900 Biscayne Blvd., Suite 630, North Miami, Florida 33181. Unless specifically amended hereby, the disclosures set forth in the Original Schedule 13D remain unchanged. Capitalized terms used but not otherwise defined herein have the meanings given to them in the Original Schedule 13D filed on September 23, 2024. Effective January 7, 2026, the Reporting Persons sold 647,505 shares of Common Stock, representing approximately 12.1% of the Issuer's outstanding Common Stock through open market transactions, since their filing of Amendment No. 9 to this Schedule 13D filed on January 2, 2026. The Reporting Persons no longer believe that the Issuer represents an attractive investment based on the Issuer's business prospects and strategy. Other than as set forth above, the Reporting Persons do not have any plans or proposals as of the date of this filing which relate to or would result in any of the actions enumerated in Item 4 of the instructions to Schedule 13D. As of the date hereof, each of Vladimir Galkin and Angelica Galkin may be deemed to beneficially own 0 shares of Common Stock, representing approximately 0.0% of the issued and outstanding shares of Common Stock of Issuer. The foregoing beneficial ownership percentages reported in this Item 5 are based on 5,350,183 shares of the Issuer's Common Stock issued and outstanding as of November 6, 2025, based on information reported by the Issuer in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, and filed with the Securities and Exchange Commission (the SEC) on November 13, 2025. See Rows 7-10 of the cover page for information regarding the power to vote or direct the vote and the power to dispose or direct the disposition of the shares of Common Stock by each of the Reporting Persons. All the transactions involving shares of Common Stock effected during the past sixty (60) days by any of the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference. Except as otherwise noted below, all such transactions were purchases and sales of shares of Common Stock effected in the open market, and the table includes commissions paid in per share prices. The Reporting Persons ceased to be the beneficial owner of more than five percent (5%) of the class of securities as of January 7, 2026. No person other than a Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, Common Stock beneficially owned by the Reporting Persons. 1. Schedule A 2. Joint Filing Agreement Galkin Vladimir Vladimir Galkin 01/07/2026 Galkin Angelica Angelica Galkin 01/07/2026